IPO registrations (S-1, F-1) · Registrants
PharmaNet Development Group Inc
- SEC CIK
- 1089542 · filings on EDGAR ↗
- Name on the registration
- SFBC INTERNATIONAL INC
- Former names
- SFBC INTERNATIONAL INC (1999–2006)
- Registration
- Form S-1, first filed 2001-11-16; 1 initial registration, 0 amendments
- Outcome
- Final prospectus filed 2001-12-17
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- 504 CARNEGIE CENTER, Princeton, NJ 08540-6242
- EIN
- 59-2407464
- EDGAR entity type
- operating
- Insiders and CEO pay
- PharmaNet Development Group Inc on the corporate pages
Offering terms
- Final price
- $16.25 per share (424B1 filed 2001-12-17)
- Shares sold
- 2,350,000 (2,000,000 by the company, 350,000 by selling holders)
- Gross proceeds
- $38,187,500 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol SFCC
- Lead underwriters
- Raymond James
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: 11190 BISCAYNE, LLC EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: BIO CLINIC MANAGEMENT COMPANY EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: PHARMANET DEVELOPMENT GROUP, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: SEARENTO TRUST LLC EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: PHARMANET DEVELOPMENT GROUP, INC. EXACT (EIN (EXACT))
- SEC filer: PharmaNet Development Group Inc EXACT (CIK (EXACT))
Filings 4
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2001-11-16 | S-1 | S-1 (registration) | SFBC INTERNATIONAL INC | 0000931763-01-502231 ↗ |
| 2001-12-17 | 424B1 | 424B1 (final prospectus) | SFBC INTERNATIONAL INC | 0000950109-01-505723 ↗ |
| 2003-06-19 | 424B4 | 424B4 (final prospectus) | SFBC INTERNATIONAL INC | 0001116502-03-001117 ↗ |
| 2003-10-31 | 424B4 | 424B4 (final prospectus) | SFBC INTERNATIONAL INC | 0000950144-03-012053 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2001-11-16 | S-1 | registration statement | $9.66 | 2,350,000 | $22,701,000 | Nasdaq SFCC | 1 | primary document; price line, shares headline, proceeds computed, cover names 1 | document ↗ | |
| 2001-12-17 | 424B1 | final prospectus | $16.25 | 2,350,000 | $38,187,500 | Nasdaq SFCC | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Golieb Arnold | Director | 7 | 2006–2009 | ||
| LEVINE JACK | Director | 10 | 2006–2008 | ||
| Boucher-Champagne Johane | Officer; Other | EVP; Exec VP of Early Clinical Dev. | 3 | 2006–2008 | |
| LEBEL MARC | Officer | EVP Bioanalytical Laboratories; Executive VP of Laboratories; See Remarks | 4 | 2006–2007 | |
| NATAN DAVID | Officer | Chief Financial Officer; EVP; Former EVP | 7 | 2006–2007 | |
| McMullen Jeffrey P | Director,Officer | Pres., CEO and Dir; Pres., CEO and Dir.; President and CEO | 4 | 2006–2009 | |
| Elias Lewis R | Director | 9 | 2006–2009 | ||
| Hamill John P | Officer | EVP and CFO; EVP, CFO, Scty, and Treas.; EVP, CFO, Scty. and Treas. | 5 | 2006–2009 | |
| LUCKING DAVID | Director | 6 | 2006–2007 | ||
| Newman Thomas Joseph | Officer | EVP; EVP, Late Stage Development | 4 | 2006–2009 | |
| CLASSON ROLF A | Director | 4 | 2006–2009 | ||
| TOMBROS PETER G | Director | 5 | 2006–2009 | ||
| OLIVIER DAVID M | Director | 4 | 2006–2009 | ||
| WOLD OLSEN PER | Director | 5 | 2006–2009 | ||
| Di Ianni Mark | Officer | EVP; EVP and Pres, Early Stage Dev.; See Remarks | 4 | 2007–2009 | |
| Sheldrick Robin Cashen | Officer | Senior VP, Human Resources | 3 | 2008–2009 | |
| FRANK RAMSEY A | Director,TenPercentOwner | 1 | 2009 | ||
| JLL Associates G.P. VI, L.L.C. | TenPercentOwner | 1 | 2009 | ||
| JLL Associates VI, L.P. | TenPercentOwner | 1 | 2009 | ||
| JLL Partners Fund VI, L.P. | TenPercentOwner | 1 | 2009 | ||
| JLL PharmaNet Holdings, LLC | TenPercentOwner | 1 | 2009 | ||
| LEVY PAUL S | Director,TenPercentOwner | 1 | 2009 | ||
| PDGI Holdco, Inc. | TenPercentOwner | 1 | 2009 | ||
| Strothman Peter M | Director,TenPercentOwner | 1 | 2009 | ||
| Taylor Thomas S | Director,TenPercentOwner | 1 | 2009 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | PHARMANET DEVELOPMENT GROUP, INC. | NJ | State business registries | name and state |
| Plan sponsor | PHARMANET DEVELOPMENT GROUP, INC. | NJ | Form 5500 (employee benefit plans) | EIN (EXACT) |
| SEC filer | PharmaNet Development Group Inc | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | PharmaNet Development Group, Inc. | NJ | Trademarks (USPTO) | name and state |
| Business registration | 11190 BISCAYNE, LLC | State business registries | EIN (EXACT, as the state registration reports it) | |
| Business registration | BIO CLINIC MANAGEMENT COMPANY | State business registries | EIN (EXACT, as the state registration reports it) | |
| Business registration | SEARENTO TRUST LLC | State business registries | EIN (EXACT, as the state registration reports it) | |
| Form 5500 plan sponsor | PHARMANET DEVELOPMENT GROUP, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, NJ first:
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- PROTALEX INC NJ
- LIFE SCIENCES RESEARCH INC NJ
- Redpoint Bio CORP NJ
- WCG Clinical, Inc. NJ
- SENTIGEN HOLDING CORP NJ
- WEED, INC. AZ
- GLYCOTEX, INC. C3
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
In other datasets, the same topic (Medical research) in NJ:
- Form D issuer: Aadi Bioscience, Inc. (Form D private offerings)
- Nonprofit: ACNE CURE ALLIANCE INC (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research